Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: J Cell Mol Med. 2011 Oct;15(10):2117–2129. doi: 10.1111/j.1582-4934.2010.01241.x

Figure 3. MPCs demonstrate poor engraftment in the ischemic myocardium.

Figure 3

Human-specific RPL32 expression (384 bp) in DNA extracts from known numbers of MPCs, untreated control rat heart and human MPC (hMPC)-treated MI hearts harvested at 24 h (N=2) and 7 d (N=2) following intramyocardial injection, was determined by PCR. Rat-specific RPL32 was used as loading control.